HR. 843In Committee
Prompt Approval of Safe Generic Drugs Act
Plain-English overview
What this bill does
Authorize FDA approval of certain generic drugs with labeling that omits patent- or exclusivity-protected safety information while still requiring safety information needed for safe use
Key points
- Require necessary safety labeling
- Authorize generic drug approval
- Allow omitted protected labeling
Current status
Where it stands
Status
In Committee
Latest action
2025-01-31 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.